Amedeo's Top 20

Amedeo Smart

Independent Medical Education

24 June 2024

Multidisciplinary Journal Club

  1. Simon GE, Moise N, Mohr DC.
    Management of Depression in Adults: A Review.
    JAMA 2024.

  1. Kelly P, Lemmens R, Weimar C, Walsh C, et al.
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet 2024.

  2. Li M, Bhoori S, Mehta N, Mazzaferro V, et al.
    Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation.
    J Hepatol 2024.

  3. Tenner S, Vege SS, Sheth SG, Sauer B, et al.
    American College of Gastroenterology Guidelines: Management of Acute Pancreatitis.
    Am J Gastroenterol 2024;119:419-437.

  4. Couzin-Frankel J.
    New Alzheimer's drug clears FDA advisory vote despite unknowns.
    Science 2024;384:1164-1165.

  1. Hardy M, Harris PNA, Paterson DL, Chatfield MD, et al.
    Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.
    Clin Infect Dis 2024;78:1482-1489.

  2. Marchand T, Lamy de La Chapelle T, Loughran TP.
    A modern view of LGL leukemia.
    Blood 2024.

  3. Williams MD, Liu Z, Rossi ED, Agarwal S, et al.
    Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents.
    J Clin Endocrinol Metab 2024.

  4. Hamilton CA, Donaghy PC, Durcan R, Ciafone J, et al.
    Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis.
    Neurology 2024;103:e209499.

  5. Prah DA, Laryea-Akrong E.
    Asymptomatic Low-Density Plasmodium falciparum Infections: Parasites Under the Host's Immune Radar?
    J Infect Dis 2024.

  1. Crawford AL, Laiteerapong N.
    Type 2 Diabetes.
    Ann Intern Med 2024.

  2. Heerspink HJL, Agarwal R, Bakris GL, Cherney DZI, et al.
    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
    Nephrol Dial Transplant 2024.

  3. Young CB, Cholerton B, Smith AM, Shahid-Besanti M, et al.
    The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
    Neurology 2024;103:e209609.

  4. Brefel-Courbon C, Harroch E, Marques A, Devos D, et al.
    Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.
    Mov Disord 2024.

  5. Chugh R, Long MD, Jiang Y, Weaver KN, et al.
    Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry.
    Am J Gastroenterol 2024;119:468-476.

  1. Reddy YNV, Kearney MD, Ward M, Burke RE, et al.
    Identifying Major Barriers to Home Dialysis (The IM-HOME Study): Findings From a National Survey of Patients, Care Partners, and Providers.
    Am J Kidney Dis 2024.

  2. Pfeuffer S, Wolff S, Aslan D, Rolfes L, et al.
    Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years.
    Neurology 2024;103:e209574.

  3. Cecchini M, Filippini T, Whelton PK, Iamandii I, et al.
    Alcohol Intake and Risk of Hypertension: A Systematic Review and Dose-Response Meta-Analysis of Nonexperimental Cohort Studies.
    Hypertension 2024.

  4. Shemer M, Shimonovitz M, Furer R, Abu-Abeid A, et al.
    Long-term outcomes and patterns of recurrence in patients with thin melanoma and a negative sentinel lymph node biopsy: a single-center experience.
    Melanoma Res 2024.

  5. Sinha P, Guerrant RL.
    The Costly Vicious Cycle of Infections and Malnutrition.
    J Infect Dis 2024;229:1611-1613.


Privacy Policy